Precision Medicine

A team of Vanderbilt researchers has developed a novel tool in the detection and analysis of structural variants in human genomes that could potentially transform genomic analysis and precision medicine. Read More

Vanderbilt University has signed an exclusive worldwide license and research collaboration agreement with Neumora Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience. Read More

On May 27, the All of Us Research Program launched the beta version of its cloud-based research platform, the Researcher Workbench. Read More

A study of 280,000 U.S. veterans, including 56,000 African Americans, has identified in greater detail than ever before the genetic architecture of kidney function and chronic kidney disease (CKD), according to researchers at Vanderbilt University Medical Center and their colleagues. Read More

The All of Us Research Program, which aims to accelerate the prevention and treatment of illness through precision medicine with the help of a million or more research participants across the United States, officially opens for national enrollment Sunday, May 6. Read More

Consuelo Wilkins, MD, MSCI, has played a major role in the development of the national All of Us Research Program, an ambitious effort led by the National Institutes of Health (NIH) to accelerate the prevention and treatment of illness through precision medicine. Read More

Consuelo Wilkins, M.D., MSCI, and Joshua Denny, M.D., M.S., discussed the potential of precision medicine during their recent Flexner Discovery Lecture. Read More

Joshua Denny, M.D., M.S., and Consuelo Wilkins, M.D., MSCI, will discuss the potential of “precision medicine” during the next Vanderbilt Cutting-Edge Discovery Lecture on Thursday, Oct. 12. Read More

Vanderbilt University Medical Center has been chosen by the National Institutes of Health to be a leader in a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people. The NIH will provide $71.6 million over five years to VUMC, making this the largest research grant the Medical Center has ever received from any source. Read More

Vanderbilt University Medical Center (VUMC) has been chosen by the National Institutes of Health (NIH) to be the Data and Research Support Center for the Precision Medicine Initiative Cohort Program, a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people, federal officials have announced. Read More

Researchers at Vanderbilt University Medical Center (VUMC), the University of Miami and Meharry Medical College were recently awarded a five-year, $11.6 million grant to launch a new center that will enable research using precision medicine to eradicate health disparities, specifically those among African-Americans and Latinos. Read More

A new clinical implementation study from Vanderbilt University Medical Center measures how physicians have responded to the introduction of routine genetic testing to predict patient response to the commonly prescribed antiplatelet drug clopidogrel. Read More

Vanderbilt University researchers have received two major federal grants — totaling $7.6 million over four years — to support groundbreaking research aimed at making genetic information a routine part of patients’ electronic medical records. Read More

Vanderbilt University researchers next month will launch a major initiative to acquire “dense genotypes” from 100,000 individuals whose medical histories are known. Read More